Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesús Zurdo

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Protein and Peptide Letters|February 23, 2005
Polypeptide models to understand misfolding and amyloidogenesis and their relevance in protein design and therapeuticsJesús Zurdo
Protein Science : a Publication of the Protein Society|February 20, 2003
Competing intrachain interactions regulate the formation of beta-sheet fibrils in bovine PrP peptidesAbdessamad Tahiri-Alaoui, Mario Bouchard, Jesús Zurdo, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|June 21, 2003
Protein folding and misfolding: a paradigm of self-assembly and regulation in complex biological systemsMichele Vendruscolo, Jesús Zurdo, Cait E MacPhee, et al.
Journal of Molecular Biology|December 21, 2005
Probing the mechanism of amyloidogenesis through a tandem repeat of the PI3-SH3 domain suggests a generic model for protein aggregation and fibril formationReto Bader, Richard Bamford, Jesús Zurdo, et al.
Journal of Molecular Biology|July 9, 2004
A highly amyloidogenic region of hen lysozymeErica Frare, Patrizia Polverino De Laureto, Jesús Zurdo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2005
Rational design of aggregation-resistant bioactive peptides: reengineering human calcitoninSusan B Fowler, Stephen Poon, Roman Muff, et al.
Journal of Molecular Biology|June 1, 2005
Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseasesAmol P Pawar, Kateri F Dubay, Jesús Zurdo, et al.
Journal of Molecular Biology|August 11, 2004
Prediction of the absolute aggregation rates of amyloidogenic polypeptide chainsKateri F DuBay, Amol P Pawar, Fabrizio Chiti, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2002
De novo designed peptide-based amyloid fibrilsManuela López De La Paz, Kenneth Goldie, Jesús Zurdo, et al.
Mabs|March 12, 2015
Aggregation risk prediction for antibodies and its application to biotherapeutic developmentOlga Obrezanova, Andreas Arnell, Ramón Gómez de la Cuesta, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Protein and Peptide Letters|February 23, 2005
Polypeptide models to understand misfolding and amyloidogenesis and their relevance in protein design and therapeuticsJesús Zurdo
Protein Science : a Publication of the Protein Society|February 20, 2003
Competing intrachain interactions regulate the formation of beta-sheet fibrils in bovine PrP peptidesAbdessamad Tahiri-Alaoui, Mario Bouchard, Jesús Zurdo, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|June 21, 2003
Protein folding and misfolding: a paradigm of self-assembly and regulation in complex biological systemsMichele Vendruscolo, Jesús Zurdo, Cait E MacPhee, et al.
Journal of Molecular Biology|December 21, 2005
Probing the mechanism of amyloidogenesis through a tandem repeat of the PI3-SH3 domain suggests a generic model for protein aggregation and fibril formationReto Bader, Richard Bamford, Jesús Zurdo, et al.
Journal of Molecular Biology|July 9, 2004
A highly amyloidogenic region of hen lysozymeErica Frare, Patrizia Polverino De Laureto, Jesús Zurdo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2005
Rational design of aggregation-resistant bioactive peptides: reengineering human calcitoninSusan B Fowler, Stephen Poon, Roman Muff, et al.
Journal of Molecular Biology|June 1, 2005
Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseasesAmol P Pawar, Kateri F Dubay, Jesús Zurdo, et al.
Journal of Molecular Biology|August 11, 2004
Prediction of the absolute aggregation rates of amyloidogenic polypeptide chainsKateri F DuBay, Amol P Pawar, Fabrizio Chiti, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2002
De novo designed peptide-based amyloid fibrilsManuela López De La Paz, Kenneth Goldie, Jesús Zurdo, et al.
Mabs|March 12, 2015
Aggregation risk prediction for antibodies and its application to biotherapeutic developmentOlga Obrezanova, Andreas Arnell, Ramón Gómez de la Cuesta, et al.
Pageof 2